» Articles » PMID: 32533221

Intercellular Communication and Ion Channels in Neuropathic Pain Chronicization

Overview
Journal Inflamm Res
Date 2020 Jun 14
PMID 32533221
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Neuropathic pain is caused by primary lesion or dysfunction of either peripheral or central nervous system. Due to its complex pathogenesis, often related to a number of comorbidities, such as cancer, neurodegenerative and neurovascular diseases, neuropathic pain still represents an unmet clinical need, lacking long-term effective treatment and complex case-by-case approach.

Aim And Methods: We analyzed the recent literature on the role of selective voltage-sensitive sodium, calcium and potassium permeable channels and non-selective gap junctions (GJs) and hemichannels (HCs) in establishing and maintaining chronic neuropathic conditions. We finally focussed our review on the role of extracellular microenvironment modifications induced by resident glial cells and on the recent advances in cell-to-cell and cell-to-extracellular environment communication in chronic neuropathies.

Conclusion: In this review, we provide an update on the current knowledge of neuropathy chronicization processes with a focus on both neuronal and glial ion channels, as well as on channel-mediated intercellular communication.

Citing Articles

Mechanistic insights into connexin-mediated neuroglia crosstalk in neurodegenerative diseases.

Denaro S, DAprile S, Vicario N, Parenti R Front Cell Neurosci. 2025; 19:1532960.

PMID: 40007760 PMC: 11850338. DOI: 10.3389/fncel.2025.1532960.


Preclinical Insights into the Role of Kir4.1 in Chronic Pain and Depression: Mechanisms and Therapeutic Potential.

Zha T, Fang X, Wan J, Chen X, Lin J, Chen Q Biomolecules. 2025; 15(2).

PMID: 40001468 PMC: 11852603. DOI: 10.3390/biom15020165.


PCAT19: the role in cancer pathogenesis and beyond.

Hu H, Luo H, Deng Z Front Cell Dev Biol. 2025; 12:1435717.

PMID: 39744012 PMC: 11688190. DOI: 10.3389/fcell.2024.1435717.


Pathophysiology-Directed Engineering of a Combination Nanoanalgesic for Neuropathic Pain.

Wang W, Wang Y, Huang X, Wu P, Li L, Zhang Y Adv Sci (Weinh). 2024; 12(8):e2405483.

PMID: 39716944 PMC: 11848598. DOI: 10.1002/advs.202405483.


TLR4 induced TRPM2 mediated neuropathic pain.

Mandlem V, Rivera A, Khan Z, Quazi S, Deba F Front Pharmacol. 2024; 15:1472771.

PMID: 39329114 PMC: 11424904. DOI: 10.3389/fphar.2024.1472771.


References
1.
Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson A, Yarnitsky D . Neuropathic pain. Nat Rev Dis Primers. 2017; 3:17002. PMC: 5371025. DOI: 10.1038/nrdp.2017.2. View

2.
Kerstman E, Ahn S, Battu S, Tariq S, Grabois M . Neuropathic pain. Handb Clin Neurol. 2013; 110:175-87. DOI: 10.1016/B978-0-444-52901-5.00015-0. View

3.
Finnerup N, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin R . Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015; 14(2):162-73. PMC: 4493167. DOI: 10.1016/S1474-4422(14)70251-0. View

4.
Felix E . Chronic neuropathic pain in SCI: evaluation and treatment. Phys Med Rehabil Clin N Am. 2014; 25(3):545-71, viii. DOI: 10.1016/j.pmr.2014.04.007. View

5.
Chou R, Turner J, Devine E, Hansen R, Sullivan S, Blazina I . The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015; 162(4):276-86. DOI: 10.7326/M14-2559. View